Gibney GT - Search Results

1

Transcriptional Profiling of Malignant Melanoma Reveals Novel and Potentially Targetable Gene Fusions.

Darabi S, Elliott A, Braxton DR, Zeng J, Hodges K, Poorman K, Swensen J, Shanthappa BU, Hinton JP, Gibney GT, Moser J, Phung T, Atkins MB, In GK, Korn WM, Eisenberg BL, Demeure MJ. Darabi S, et al. Among authors: gibney gt. Cancers (Basel). 2022 Mar 15;14(6):1505. doi: 10.3390/cancers14061505. Cancers (Basel). 2022. PMID: 35326655 Free PMC article.

2

Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.

Gibney GT, Atkins MB. Gibney GT, et al. J Clin Oncol. 2015 Jun 10;33(17):1873-7. doi: 10.1200/JCO.2014.60.1807. Epub 2015 May 11. J Clin Oncol. 2015. PMID: 25964248

3

Immunotherapy or molecularly targeted therapy: what is the best initial treatment for stage IV BRAF-mutant melanoma?

Gibney GT, Atkins MB. Gibney GT, et al. Clin Adv Hematol Oncol. 2015 Jul;13(7):451-8. Clin Adv Hematol Oncol. 2015. PMID: 26353041 Review.

4

Advances in immunotherapy for melanoma.

Redman JM, Gibney GT, Atkins MB. Redman JM, et al. Among authors: gibney gt. BMC Med. 2016 Feb 6;14:20. doi: 10.1186/s12916-016-0571-0. BMC Med. 2016. PMID: 26850630 Free PMC article. Review.

5

Predictive biomarkers for checkpoint inhibitor-based immunotherapy.

Gibney GT, Weiner LM, Atkins MB. Gibney GT, et al. Lancet Oncol. 2016 Dec;17(12):e542-e551. doi: 10.1016/S1470-2045(16)30406-5. Lancet Oncol. 2016. PMID: 27924752 Free PMC article. Review.

6

Choice of first-line therapy in metastatic melanoma.

Gibney GT, Atkins MB. Gibney GT, et al. Cancer. 2019 Mar 1;125(5):666-669. doi: 10.1002/cncr.31774. Epub 2019 Jan 29. Cancer. 2019. PMID: 30695110 Free article. No abstract available.

7

YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.

White SM, Avantaggiati ML, Nemazanyy I, Di Poto C, Yang Y, Pende M, Gibney GT, Ressom HW, Field J, Atkins MB, Yi C. White SM, et al. Among authors: gibney gt. Dev Cell. 2019 May 6;49(3):425-443.e9. doi: 10.1016/j.devcel.2019.04.014. Dev Cell. 2019. PMID: 31063758 Free PMC article.

8

The current state of molecular testing in the treatment of patients with solid tumors, 2019.

El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, Brown J, Eisenberg B, Heath EI, Phuphanich S, Kim E, Brenner AJ, Marshall JL. El-Deiry WS, et al. Among authors: gibney gt. CA Cancer J Clin. 2019 Jul;69(4):305-343. doi: 10.3322/caac.21560. Epub 2019 May 22. CA Cancer J Clin. 2019. PMID: 31116423 Free PMC article. Review.

9

Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection.

Shah NJ, Al-Shbool G, Blackburn M, Cook M, Belouali A, Liu SV, Madhavan S, He AR, Atkins MB, Gibney GT, Kim C. Shah NJ, et al. Among authors: gibney gt. J Immunother Cancer. 2019 Dec 17;7(1):353. doi: 10.1186/s40425-019-0771-1. J Immunother Cancer. 2019. PMID: 31847881 Free PMC article.

10

Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases.

In GK, Poorman K, Saul M, O'Day S, Farma JM, Olszanski AJ, Gordon MS, Thomas JS, Eisenberg B, Flaherty L, Weise A, Daveluy S, Gibney G, Atkins MB, Vanderwalde A. In GK, et al. Oncotarget. 2020 Aug 18;11(33):3118-3128. doi: 10.18632/oncotarget.27686. eCollection 2020 Aug 18. Oncotarget. 2020. PMID: 32913556 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page